Retatrutide (GLP-1 / GIP / Glucagon Triple Agonist)
The most-requested triple agonist in metabolic research — batch-verified and shipped from the U.S.
Drag the vial to rotate the label
By adding to cart, purchaser certifies the materials are being acquired solely for legitimate laboratory research purposes. Not for human or veterinary use.
The most-requested triple agonist in metabolic research — batch-verified and shipped from the U.S.
Retatrutide is a synthetic 39-amino-acid peptide that engages three incretin-family receptors — GLP-1R, GIP-R, and the glucagon receptor — simultaneously. Research groups use it in receptor binding and downstream cAMP / β-arrestin recruitment assays to characterize the balanced pharmacology of tri-agonists relative to dual (GLP-1/GIP) and mono agonists. Its extended half-life analog design supports in-vitro stability and comparative potency work in cultured adipocyte and hepatocyte models. Supplied as a sterile lyophilized powder for reconstitution in bacteriostatic water. For laboratory research use only — not for human or veterinary use.
- GLP-1/GIP/glucagon receptor signaling
- cAMP downstream assays
- Metabolic pathway modeling
- Independently verified for identity and purity on a batch-specific basis.
- Certificates of analysis publicly accessible by lot ID — never averaged.
- Sourced through qualified manufacturing partners and shipped from the United States.
- Fast shipping, always tracked, shipped from the United States.
